查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009095

胃内球囊市场规模、份额、趋势和预测：按产品、填充材、植入方法、应用、最终用户和地区划分（2026-2034 年）

Intragastric Balloons Market Size, Share, Trends and Forecast by Product, Filling Material, Implanting Procedure, Application, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2025年全球胃内球囊市场规模为7,710万美元。展望未来，IMARC集团预测，该市场将以9.67%的复合年增长率从2026年增长至2034年，到2034年达到1.844亿美元。北美在2025年占据市场领先地位。高肥胖率、先进的医疗保健系统、FDA的早期核准以及对非手术减重方法日益增长的需求，都是推动胃内球囊市场份额扩张的因素。

由于全球肥胖率上升以及与超重相关的健康问题日益严重，胃内球囊市场正蓬勃发展。这些球囊提供了一种非手术、暂时性的减重方案，并因其无需手术即可达到理想效果而受到寻求侵入性手术替代方案的患者的青睐。数位健康宣传活动和医疗专业人士的推荐提高了公众意识，进一步推动了市场需求。可吞嚥、充气或可调节球囊等技术的进步提高了患者的舒适度，并扩大了适应症范围。此外，一些国家的保险覆盖范围以及医疗旅游的兴起，尤其是在提供价格合理的内视镜手术的地区，也促进了球囊的普及。新市场的监管核准扩大了球囊的准入范围，而支持球囊短期减重成效的临床证据也提高了其可信度。所有这些因素共同为胃内球囊市场的成长创造了有利环境，尤其是在文明病日益增加的都市区。

米国では、胃内球囊システムの新たな设计により、非外科的な减重法が进歩しています。时间设定による减圧と自然排泄が可能な饮み込み可能なカプセルは、利便性と安全性をさらに高めています。知的财产権の保护が今后10年间にわたって継続される中、こうした革新は、より広范な利用と临床的な受容に向けた土台を筑いています。例えば、2025年4月、ReShape Lifesciences社は、胃内球囊に関する特许（出愿番号18/241,151）について、米国特许商标庁（USPTO）から许可通知を受け取りました。この特许は、自己密闭式の充填バルブと生分解性の放出バルブを备えた饮み込み可能なカプセルを対象としており、3ヶ月后に収缩して自然に排泄されるように设计されています。このシステムは、非外科的减重ソリューションに革新をもたらします。この特许は、一旦発行されれば、少なくとも2031年1月まで保护が提供されます。

胃内球囊市场的发展趋势：

对非手术减重方法的需求日益增长

鑑于与体重相关的健康问题普遍存在，以及人们对非侵入性治疗的兴趣日益浓厚，胃内球囊市场前景仍然光明。对于那些希望在医疗监督下进行非手术减重的人来说，胃内球囊正逐渐成为首选方案。由于其可逆且微创，患者和临床医生都倾向于选择这种装置，以避免漫长的恢復期和永久性的解剖结构改变。另一个吸引人的特点是，在医疗指导下，这些手术可以与生活方式的改变结合。随着医疗保健系统面临着应对肥胖相关疾病的压力，人们对安全、有效且经济的早期疗育越来越感兴趣。宣传宣传活动和医学界的广泛认可进一步推动了这种治疗方法的普及，尤其是在那些难以获得先进外科手术治疗的地区。根据世界卫生组织（WHO）统计，到2022年，全球有25亿18岁以上的成年人超重，其中8.9亿人肥胖。

过渡到微创手术进行体重管理

在临床实务中，传统开放性手术正逐渐被微创方法所取代。切口更小、住院时间更短、恢復更快的治疗方式正日益受到医护人员和病患的青睐。根据对胃内球囊市场的预测，这一转变反映了体重管理方法的整体变革，更加重视安全性、便利性和减少术后併发症。胃内球囊完美契合了这一趋势，为寻求低风险解决方案的患者提供了临时性的非手术选择。随着越来越多的医护人员采用微创方法，此类设备在註重患者舒适度和门诊模式的临床环境中得到了更广泛的应用。韩国最近的一项调查显示，开放性手术正逐渐被微创技术取代。开放性手术的比例从2014年的49.8%下降到2019年的27.6%。

对非手术减重设备有效性的评估日益增加。

临床研究正在增强人们对非手术减重疗法的信心。胃内球囊因其与生活方式介入相结合时能够带来显着效果而备受关注。近期临床试验数据证实，长期使用可实现持续减重，且安全性良好，这支持了其在寻求非手术减重方案的患者中的更广泛应用。这些发现正在影响医生的决策，并可能影响监管路径，从而促进其更广泛应用。人们对能够以最小风险获得可衡量效果的治疗方法（尤其是在与系统性生活方式介入相结合的情况下）的兴趣持续增长。在临床实务和病患偏好方面，微创方法的转变日益明显。这反映了胃内球囊市场的整体趋势，即关注安全性、便利性和长期疗效。例如，2025年1月，Allurion Technologies公司公布了其Allurion球囊的FDA领先临床试验「AUDACITY」的主要结果。该试验招募了550多名参与者，他们接受了两次球囊治疗或生活方式介入。 48週时，接受球囊血管成形术的患者中有58%体重减轻了5%或更多。虽然与对照组（3.77%）相比，减重的差异未达3%的统计学显着性优势界值，但在40週时已超过该界值。严重不利事件的发生率较低，为3.1%。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球胃内球囊市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 单胃内球囊
  • 双胃内球囊
  • 三联胃内球囊

第七章 市场区隔：依填充材划分

  • 充满生理食盐水
  • 充气

第八章 市场细分：依植入手术分类

  • 外科
  • 非手术

第九章 市场区隔：依应用领域划分

  • 肥胖
  • 糖尿病
  • 饮食管理
  • 减重
  • 术前减重
  • 其他的

第十章 市场区隔：依最终用户划分

  • 医院和诊所
  • 门诊手术中心
  • 其他的

第十一章 市场区隔：按地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十二章 SWOT 分析

第十三章：价值链分析

第十四章：波特五力分析

第十五章：价格指标

第十六章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Apollo Endosurgery
    • Obalon Therapeutics Inc.
    • ReShape Medical Inc.
    • Medicone
    • Medsil
    • Allurion Technologies Inc.
    • Helioscopie
    • Spatz Fgia Inc.
    • PlenSat
    • Districlass Medical SA
    • Endalis
    • Lexel SRL
    • Silimed Inc.
    • Shandong Institute of Medical Instruments
Product Code: SR112026A2085

The global intragastric balloons market size was valued at USD 77.1 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 184.4 Million by 2034, exhibiting a CAGR of 9.67% during 2026-2034. North America dominated the market in 2025. High obesity rates, advanced healthcare, early FDA approvals, and growing demand for non-surgical weight loss are some of the factors contributing to the intragastric balloons market share.

The market is gaining traction due to increasing global obesity rates and rising health concerns linked to excess weight. These balloons offer a non-surgical, temporary weight loss solution, appealing to patients seeking alternatives to invasive procedures. Growing awareness through digital health campaigns and recommendations by healthcare providers has further boosted demand. Technological improvements, such as swallowable, gas-filled, or adjustable balloons, enhance patient comfort and broaden eligibility. Additionally, supportive insurance policies in some countries and the growth of medical tourism, particularly in regions offering affordable endoscopic procedures, are driving adoption. Regulatory approvals across new markets are expanding accessibility, and clinical evidence supporting balloon effectiveness for short-term weight loss adds to their credibility. Combined, these factors create a favorable environment for intragastric balloons market growth, especially in urban areas with rising lifestyle-related health issues.

In the United States, new designs in intragastric balloon systems are advancing non-surgical weight loss methods. A swallowable capsule with timed deflation and natural excretion introduces added convenience and safety. As intellectual property protections extend into the next decade, such innovations are setting the stage for broader use and clinical acceptance. For instance, in April 2025, ReShape Lifesciences received a Notice of Allowance from the USPTO for its intragastric balloon patent (application 18/241,151). The patent covers a swallowable capsule with a self-sealing fill valve and a degradable release valve, designed to deflate after three months and be naturally excreted. This system adds innovation to non-surgical weight loss solutions. The patent, once issued, offers protection through at least January 2031.

INTRAGASTRIC BALLOONS MARKET TRENDS:

Growing Demand for Non-Surgical Weight Loss Alternatives

The intragastric balloons market outlook remains positive as widespread weight-related health issues are pushing interest in non-invasive treatments. Intragastric balloons are becoming a preferred option for those seeking medically supervised weight loss without surgery. These devices offer a reversible and less intensive approach, which appeals to both patients and clinicians aiming to avoid long recovery periods or permanent anatomical changes. The appeal also lies in the ability to integrate these procedures with lifestyle changes under medical guidance. As healthcare systems face mounting pressure to manage obesity-related conditions, there's a stronger emphasis on early intervention methods that are safe, effective, and cost-conscious. Awareness campaigns and broader acceptance within medical communities are further reinforcing adoption, especially in regions with limited access to advanced surgical care. The World Health Organization (WHO) reported that in 2022, 2.5 Billion adults aged 18 and above were overweight, with 890 Million of them living with obesity.

Shift toward Minimally Invasive Procedures in Weight Management

Clinical preferences are steadily moving away from traditional open surgery in favor of less invasive methods. Procedures that require smaller incisions, shorter hospital stays, and quicker recovery times are gaining favor among both practitioners and patients. Based on the intragastric balloons market forecast, this shift reflects a broader change in how weight-related interventions are approached, favoring safety, convenience, and reduced post-operative complications. Intragastric balloons fit neatly into this movement, offering a temporary, non-surgical option that aligns with patient demand for low-risk solutions. As more medical professionals adopt minimally invasive approaches, devices like these are seeing wider use in clinical settings that prioritize patient comfort and outpatient care models. A recent survey in Korea showed a shift from open surgery to minimally invasive techniques. The rate of open surgery dropped from 49.8% in 2014 to 27.6% in 2019.

Increased Validation of Non-Surgical Weight Loss Devices

Clinical studies are reinforcing confidence in non-surgical weight loss options. Intragastric balloons are drawing attention for their ability to deliver meaningful results alongside lifestyle programs. Recent trial data highlights sustained weight reduction over time with a favorable safety profile, supporting wider use in patients seeking alternatives to surgery. These findings are influencing physician decisions and could shape regulatory pathways for broader adoption. Interest continues to grow in treatments that offer measurable outcomes with minimal risk, especially when combined with structured lifestyle support. The shift toward less invasive methods is becoming more pronounced in clinical practice and patient preference alike. This reflects broader intragastric balloons market trends focused on safety, convenience, and long-term effectiveness. For example, in January 2025, Allurion Technologies reported topline results from its FDA pivotal AUDACITY trial on the Allurion Balloon. Over 550 participants joined, receiving two balloon cycles or lifestyle therapy. At 48 weeks, 58% of balloon recipients lost over 5% of body weight. Though the weight loss difference vs. controls (3.77%) missed the 3% superiority margin statistically, the margin was exceeded at 40 weeks. Serious adverse events were low at 3.1%.

INTRAGASTRIC BALLOONS INDUSTRY SEGMENTATION:

Analysis by Product:

  • Single Intragastric Balloon
  • Double Intragastric Balloon
  • Triple Intragastric Balloon

Single intragastric balloon stood as the largest product in 2025. This type of balloon is gaining traction due to its simpler placement procedure, lower cost compared to dual or adjustable variants, and fewer associated complications. It's usually inserted endoscopically and removed after six months, offering a less invasive alternative to bariatric surgery for short-term weight loss. Patients and clinicians often prefer this option for its safety profile, faster recovery, and minimal maintenance. As obesity rates climb and demand grows for non-surgical weight loss methods, single-balloon systems are seeing wider adoption across clinics. Their convenience and growing clinical acceptance make them a leading contributor to market expansion.

Analysis by Filling Material:

  • Saline Filling
  • Gas Filling

Saline filling led the market in 2025. These balloons are filled with sterile saline solution after placement in the stomach, making them safer and more widely accepted. Saline allows easy visualization on imaging, which helps in monitoring and ensures prompt response to any deflation. They also come with a blue dye indicator; if leakage occurs, the dye colors the urine, acting as an early warning system. This safety feature, combined with affordability and a long track record of clinical use, makes saline-filled balloons more appealing than gas-filled options. Their predictable performance and broader physician preference are accelerating their adoption, especially in outpatient settings and emerging markets where cost and reliability are key factors.

Analysis by Implanting Procedure:

  • Surgical
  • Non-Surgical

Non-surgical led the market in 2025 as more patients seek weight loss solutions that avoid the risks, recovery time, and cost of surgery. Intragastric balloons offer a minimally invasive approach, typically placed and removed via endoscopy or swallowed in capsule form, making them accessible to a wider population, including those who are not candidates for bariatric surgery. This appeals to individuals looking for a temporary, reversible option with fewer complications. Clinics and providers are also expanding their offerings to include non-surgical procedures to meet rising demand. The growing interest in outpatient and office-based treatments further supports this trend. Convenience, safety, and faster return to daily activities are making the non-surgical segment a key growth driver in this market.

Analysis by Application :

  • Obesity
  • Diabetes
  • Diet Control
  • Weight-Loss
  • Pre-Operative Weight Reduction
  • Others

Obesity led the market in 2025. With global obesity rates climbing steadily, more individuals are seeking effective weight management options beyond diet and exercise. Intragastric balloons offer a non-permanent, non-surgical intervention that supports initial weight loss and motivates lifestyle change. They are especially useful for patients with moderate obesity who may not qualify for bariatric surgery but still need medical intervention. As obesity is linked to conditions like diabetes, hypertension, and heart disease, healthcare providers are recommending earlier weight management strategies, including balloons. Rising awareness, insurance coverage improvements, and government health initiatives targeting obesity are also contributing to increased adoption, making the obesity segment a strong driver of market growth.

Analysis by End-User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Hospitals and clinics led the market in 2025, owing to their access to trained gastroenterologists, advanced endoscopic equipment, and post-procedure care. These settings are preferred for balloon placement and removal because they offer higher safety standards, patient monitoring, and comprehensive weight management programs. As awareness grows, more patients are turning to hospitals and specialty clinics for non-surgical obesity treatments. The rise in outpatient services and day-care procedures has made balloon insertion more convenient and cost-effective in these environments. Additionally, hospitals often partner with wellness programs and dieticians, offering patients a full treatment path. Their credibility, infrastructure, and capacity to handle complications make hospitals and clinics the go-to centers, boosting the segment's impact on market expansion.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share. The region has one of the highest obesity rates globally, creating strong demand for effective, non-surgical weight-loss solutions. The presence of advanced healthcare infrastructure and well-established medical facilities enables widespread adoption of intragastric balloon procedures. Additionally, North America benefits from early regulatory approvals by agencies like the FDA, allowing quicker market access for innovative devices. High awareness levels among patients and healthcare professionals, along with strong marketing efforts by key manufacturers, also contribute to regional growth. Insurance coverage and reimbursement options in some areas further support patient access. Moreover, a growing preference for outpatient and minimally invasive procedures aligns well with balloon treatments. These combined factors continue to strengthen North America's leading position in the global intragastric balloons market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES INTRAGASTRIC BALLOONS MARKET ANALYSIS

The United States intragastric balloons market is primarily driven by the rising prevalence of obesity and related health complications. According to the new 2023 CDC population data, over one in three adults (35%) in 23 states are affected by obesity. Also, at least one in five adults (20%) in every U.S. state is currently living with obesity. In line with this, continual advances in balloon technology have significantly improved the safety and efficacy of procedures, attracting more patients to the market. The increasing awareness of non-surgical weight loss options is further driving market growth as individuals seek alternatives to traditional surgical procedures. Similarly, the growing preference for minimally invasive procedures, offering faster recovery times, is also fueling market demand. Furthermore, the heightened emphasis on preventive healthcare, motivating people to manage their weight actively, is fostering market expansion. Additionally, the rising trend of medical tourism is contributing to the market appeal as patients seek cost-effective solutions abroad. Moreover, favorable government initiatives and policies focused on obesity management are creating a supportive environment for market development, accelerating the adoption of intragastric balloon treatments.

EUROPE INTRAGASTRIC BALLOONS MARKET ANALYSIS

The market for intragastric balloons in Europe is experiencing growth due to the increasing prevalence of obesity and related chronic conditions. In accordance with this, the growing awareness of non-surgical weight loss options is encouraging patients to opt for minimally invasive treatments. Furthermore, ongoing advancements in intragastric balloon technology, which offers improved safety and effectiveness, are enhancing market appeal. The rise of medical tourism in Europe, where patients seek cost-effective solutions, is also contributing to market expansion. Additionally, supportive healthcare policies and reimbursement schemes across European countries are improving access to these treatments. The aging population in Europe, more prone to obesity, is another key market driver. The 2022 Health Survey for England found that individuals aged 55 to 74 were more likely to be overweight or obese compared to other age groups, with over 70% of people in these age ranges having excess weight. Additionally, preventive healthcare initiatives and a growing focus on wellness are fueling demand for weight management solutions. Apart from this, numerous collaborations between healthcare providers and research institutions are fostering innovation, further impacting market trends.

ASIA PACIFIC INTRAGASTRIC BALLOONS MARKET ANALYSIS

The Asia Pacific market is predominantly driven by rapid urbanization and changing dietary habits, resulting in a larger patient base. In addition to this, growing awareness of minimally invasive procedures is prompting more individuals to opt for intragastric balloons as a non-surgical option. Furthermore, supportive government initiatives focusing on obesity management and preventive healthcare are fostering market growth. The region's increasing access to advanced medical technologies, which enhance the safety and effectiveness of treatments, is strengthening the market demand. Moreover, the expanding middle class, with higher disposable incomes, is fueling demand for weight loss treatments, providing further market potential. According to the People Research on India's Consumer Economy (PRICE), India's middle class is the fastest-growing segment, expanding at a rate of 6.3% annually, with an increase of 338 Million people from 1995 to 2021. It now constitutes 31% of the population and is projected to reach 38% by 2031 and 60% by 2047.

LATIN AMERICA INTRAGASTRIC BALLOONS MARKET ANALYSIS

In Latin America, the market for intragastric balloons is expanding, predominantly driven by rising disposable income, which enables more individuals to afford weight loss treatments. Similarly, increasing awareness of minimally invasive procedures is encouraging individuals to opt for non-surgical options. The growing availability of advanced medical technologies, enhancing the safety and efficacy of treatments, is further fueling market expansion. Moreover, favorable government initiatives focused on addressing obesity through public health campaigns and improving healthcare access are making these treatments more accessible, strengthening the market's presence. As such, Novo Nordisk planned to invest USD 1.09 Billion in Brazil to expand production of Ozempic, Wegovy, and other injectable drugs. The investment will enhance manufacturing capacity at its Minas Gerais facility, with operations set to begin in 2028.

MIDDLE EAST AND AFRICA INTRAGASTRIC BALLOONS MARKET ANALYSIS

The market in the Middle East and Africa is significantly influenced by the growing awareness of obesity-related health risks and the need for effective weight loss solutions. The 2023 update from the World Obesity Federation's Global Observatory revealed that the UAE has a childhood obesity prevalence rate of 15% among girls (ranked 24th globally) and 18.5% among boys (ranked 21st globally). Furthermore, increasing access to modern medical treatments in the region, bolstered by investments in healthcare infrastructure, is accelerating market demand. Additionally, the region's growing health-conscious population, particularly among younger generations, is driving the need for minimally invasive weight loss options, thereby impelling the market. Moreover, various collaborative partnerships between local healthcare providers and global medical device companies are enhancing the availability and affordability of these treatments, providing an impetus to the market.

COMPETITIVE LANDSCAPE:

The intragastric balloon market is seeing steady activity with ongoing product launches, regulatory approvals, and research-driven innovation. Companies are introducing adjustable and non-invasive balloon systems to improve safety and patient comfort. Partnerships, mergers, and funding rounds are being used to expand product portfolios and global reach. Research institutions are contributing to the development of next-generation capsules with automated inflation features. While government initiatives mainly support obesity awareness and prevention, they indirectly benefit market growth. Among these, research and development, along with commercial partnerships, remain the most common practices, helping companies differentiate their offerings and meet regulatory requirements in new markets.

The report provides a comprehensive analysis of the competitive landscape in the intragastric balloons market with detailed profiles of all major companies, including:

  • Apollo Endosurgery
  • Obalon Therapeutics Inc.
  • ReShape Medical Inc.
  • Medicone
  • Medsil
  • Allurion Technologies Inc.
  • Helioscopie
  • Spatz Fgia Inc.
  • PlenSat
  • Districlass Medical SA
  • Endalis
  • Lexel SRL
  • Silimed Inc.
  • Shandong Institute of Medical Instruments

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the intragastric balloons market?

2. What is the future outlook of intragastric balloons market?

3. What are the key factors driving the intragastric balloons market?

4. Which region accounts for the largest intragastric balloons market share?

5. Which are the leading companies in the global intragastric balloons market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intragastric Balloons Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single Intragastric Balloon
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Double Intragastric Balloon
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Triple Intragastric Balloon
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Filling Material

  • 7.1 Saline Filling
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gas Filling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Implanting Procedure

  • 8.1 Surgical
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-Surgical
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Obesity
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diet Control
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Weight-Loss
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Pre-Operative Weight Reduction
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Apollo Endosurgery
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Obalon Therapeutics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 ReShape Medical Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Medicone
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medsil
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Allurion Technologies Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Helioscopie
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Spatz Fgia Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 PlenSat
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Districlass Medical SA
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Endalis
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Lexel SRL
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
    • 16.3.13 Silimed Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
    • 16.3.14 Shandong Institute of Medical Instruments
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intragastric Balloons Market: Major Drivers and Challenges
  • Figure 2: Global: Intragastric Balloons Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Intragastric Balloons Market: Breakup by Product (in %), 2025
  • Figure 4: Global: Intragastric Balloons Market: Breakup by Filling Material (in %), 2025
  • Figure 5: Global: Intragastric Balloons Market: Breakup by Implanting Procedure (in %), 2025
  • Figure 6: Global: Intragastric Balloons Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Intragastric Balloons Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Intragastric Balloons Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Intragastric Balloons (Single Intragastric Balloon) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Intragastric Balloons (Single Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Intragastric Balloons (Double Intragastric Balloon) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Intragastric Balloons (Double Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Intragastric Balloons (Triple Intragastric Balloon) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Intragastric Balloons (Triple Intragastric Balloon) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Intragastric Balloons (Saline Filling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Intragastric Balloons (Saline Filling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Intragastric Balloons (Gas Filling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Intragastric Balloons (Gas Filling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Intragastric Balloons (Surgical Implant) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Intragastric Balloons (Surgical Implant) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Intragastric Balloons (Non-Surgical Implant) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Intragastric Balloons (Non-Surgical Implant) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Intragastric Balloons (Obesity) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Intragastric Balloons (Obesity) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Intragastric Balloons (Diabetes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Intragastric Balloons (Diabetes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Intragastric Balloons (Diet Control) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Intragastric Balloons (Diet Control) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Intragastric Balloons (Weight-Loss) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Intragastric Balloons (Weight-Loss) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Intragastric Balloons (Pre-Operative Weight Reduction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Intragastric Balloons (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Intragastric Balloons (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Intragastric Balloons (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Intragastric Balloons (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Intragastric Balloons (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Intragastric Balloons (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Intragastric Balloons (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: North America: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: North America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: United States: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: United States: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Canada: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Canada: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Asia Pacific: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Asia Pacific: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: China: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: China: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Japan: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Japan: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: India: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: India: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: South Korea: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: South Korea: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Australia: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Australia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Indonesia: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Indonesia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Europe: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Europe: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Germany: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Germany: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: France: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: France: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: United Kingdom: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: United Kingdom: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Italy: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Italy: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Spain: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Spain: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Russia: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Russia: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Latin America: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Latin America: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Brazil: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Brazil: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Mexico: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Mexico: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Middle East and Africa: Intragastric Balloons Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Middle East and Africa: Intragastric Balloons Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Global: Intragastric Balloons Industry: SWOT Analysis
  • Figure 91: Global: Intragastric Balloons Industry: Value Chain Analysis
  • Figure 92: Global: Intragastric Balloons Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intragastric Balloons Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Intragastric Balloons Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Intragastric Balloons Market Forecast: Breakup by Filling Material (in Million USD), 2026-2034
  • Table 4: Global: Intragastric Balloons Market Forecast: Breakup by Implanting Procedure (in Million USD), 2026-2034
  • Table 5: Global: Intragastric Balloons Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Intragastric Balloons Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 7: Global: Intragastric Balloons Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Intragastric Balloons Market: Competitive Structure
  • Table 9: Global: Intragastric Balloons Market: Key Players